BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31927625)

  • 1. Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.
    Chantrapanichkul P; Indhavivadhana S; Wongwananuruk T; Techatraisak K; Dangrat C; Sa-Nga-Areekul N
    Arch Gynecol Obstet; 2020 Mar; 301(3):809-816. PubMed ID: 31927625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
    Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
    Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone.
    Lee MS; Lanes A; Dolinko AV; Bailin A; Ginsburg E
    J Assist Reprod Genet; 2020 Sep; 37(9):2293-2304. PubMed ID: 32623663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies.
    Anagnostis P; Paparodis RD; Bosdou JK; Bothou C; Macut D; Goulis DG; Livadas S
    Endocrine; 2021 Nov; 74(2):245-253. PubMed ID: 34176074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Phoenixin-14 levels of women with polycystic ovary syndrome increase proportionally with BMI.
    Cundubey CR; Cam SD
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3519-3525. PubMed ID: 37140302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome.
    Patel-Sanchez N; Perito E; Tsai P; Raymond-Flesch M; Lodish M; Sarkar M
    J Pediatr Endocrinol Metab; 2023 May; 36(5):441-446. PubMed ID: 37060356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting Glucose Changes in Adolescents with Polycystic Ovary Syndrome Compared with Obese Controls: A Retrospective Cohort Study.
    Javed A; Lteif AN; Kumar S; Simmons PS; Chang AY
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):451-6. PubMed ID: 26238569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.
    Kakoly NS; Earnest A; Teede HJ; Moran LJ; Joham AE
    Diabetes Care; 2019 Apr; 42(4):560-567. PubMed ID: 30705063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome.
    Chen CI; Hsu MI; Lin SH; Chang YC; Hsu CS; Tzeng CR
    Gynecol Endocrinol; 2015 Apr; 31(4):264-8. PubMed ID: 25423261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose metabolism in women with polycystic ovary syndrome.
    Vrbikova J; Fanta M; Cibula D; Vondra K; Bendlova B
    Gynecol Obstet Invest; 2009; 68(3):186-90. PubMed ID: 19672087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index stratified meta-analysis of genome-wide association studies of polycystic ovary syndrome in women of European ancestry.
    Burns K; Mullin BH; Moolhuijsen LME; Laisk T; Tyrmi JS; Cui J; Actkins KV; Louwers YV; ; Davis LK; Dudbridge F; Azziz R; Goodarzi MO; Laivuori H; Mägi R; Visser JA; Laven JSE; Wilson SG; ; ; Day FR; Stuckey BGA
    BMC Genomics; 2024 Feb; 25(1):208. PubMed ID: 38408933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome.
    Bailey AP; Hawkins LK; Missmer SA; Correia KF; Yanushpolsky EH
    Am J Obstet Gynecol; 2014 Aug; 211(2):163.e1-6. PubMed ID: 24657792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.
    Long C; Feng H; Duan W; Chen X; Zhao Y; Lan Y; Yue R
    Front Endocrinol (Lausanne); 2022; 13():980405. PubMed ID: 36120432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].
    Shi YH; Zhao DN; Zhao JL; You L; Liu H; Sun M; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):575-7. PubMed ID: 21029611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.
    Alebić MŠ; Bulum T; Stojanović N; Duvnjak L
    Endocrine; 2014 Nov; 47(2):625-30. PubMed ID: 24522614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ART outcomes in lean compared to obese phenotypes of polycystic ovarian syndrome.
    Fouks Y; Neuhausser W; Ryley D; Penzias A; Sakkas D; Vaughan D
    J Assist Reprod Genet; 2023 Jun; 40(6):1437-1445. PubMed ID: 37212942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.
    Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Endocr J; 2013; 60(9):1107-13. PubMed ID: 23801024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.